Druggable differences: Targeting mechanistic differences between trans-translation and translation for selective antibiotic action

Bioessays. 2022 Aug;44(8):e2200046. doi: 10.1002/bies.202200046. Epub 2022 Jun 19.

Abstract

Bacteria use trans-translation to rescue stalled ribosomes and target incomplete proteins for proteolysis. Despite similarities between tRNAs and transfer-messenger RNA (tmRNA), the key molecule for trans-translation, new structural and biochemical data show important differences between translation and trans-translation at most steps of the pathways. tmRNA and its binding partner, SmpB, bind in the A site of the ribosome but do not trigger the same movements of nucleotides in the rRNA that are required for codon recognition by tRNA. tmRNA-SmpB moves from the A site to the P site of the ribosome without subunit rotation to generate hybrid states, and moves from the P site to a site outside the ribosome instead of to the E site. During catalysis, transpeptidation to tmRNA appears to require the ribosomal protein bL27, which is dispensable for translation, suggesting that this protein may be conserved in bacteria due to trans-translation. These differences provide insights into the fundamental nature of trans-translation, and provide targets for new antibiotics that may have decrease cross-reactivity with eukaryotic ribosomes.

Keywords: antibiotics; protein synthesis; ribosome; tRNA; tmRNA; trans-translation; translation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents* / metabolism
  • Anti-Bacterial Agents* / pharmacology
  • Protein Biosynthesis
  • RNA, Transfer / metabolism
  • RNA-Binding Proteins* / metabolism
  • Ribosomes / metabolism

Substances

  • Anti-Bacterial Agents
  • RNA-Binding Proteins
  • RNA, Transfer